| Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections R Nau, F Sörgel, H Eiffert Clinical microbiology reviews 23 (4), 858-883, 2010 | 999 | 2010 |
| N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins F Higel, A Seidl, F Sörgel, W Friess European journal of pharmaceutics and biopharmaceutics 100, 94-100, 2016 | 417 | 2016 |
| Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations CB Landersdorfer, JB Bulitta, M Kinzig, U Holzgrabe, F Sörgel Clinical pharmacokinetics 48, 89-124, 2009 | 345 | 2009 |
| Acrylamide: increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans F Sörgel, R Weissenbacher, M Kinzig-Schippers, A Hofmann, M Illauer, ... Chemotherapy 48 (6), 267-274, 2003 | 274 | 2003 |
| Should We Use N-Acetyltransferase Type 2 Genotyping To Personalize Isoniazid Doses? M Kinzig-Schippers, D Tomalik-Scharte, A Jetter, B Scheidel, V Jakob, ... Antimicrobial agents and chemotherapy 49 (5), 1733-1738, 2005 | 255 | 2005 |
| Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity U Fuhr, MI Boettcher, M Kinzig-Schippers, A Weyer, A Jetter, A Lazar, ... Cancer Epidemiology Biomarkers & Prevention 15 (2), 266-271, 2006 | 237 | 2006 |
| Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis N Nagy, T Freudenberger, A Melchior-Becker, K Röck, M Ter Braak, ... Circulation 122 (22), 2313-2322, 2010 | 206 | 2010 |
| Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis HW Pfister, V Preac-Mursic, B Wilske, E Schielke, F Sörgel, KM Einhaupl Journal of Infectious Diseases 163 (2), 311-318, 1991 | 203 | 1991 |
| The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam F Sörgel, M Kinzig Journal of Antimicrobial Chemotherapy 31 (suppl_A), 39-60, 1993 | 197 | 1993 |
| Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta … C Lübbert, C Baars, A Dayakar, N Lippmann, AC Rodloff, M Kinzig, ... Infection 45 (4), 479-491, 2017 | 196 | 2017 |
| Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial SG Sakka, AK Glauner, JB Bulitta, M Kinzig-Schippers, W Pfister, ... Antimicrobial agents and chemotherapy 51 (9), 3304-3310, 2007 | 190 | 2007 |
| Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro U Fuhr, EM Anders, G Mahr, F Sörgel, AH Staib Antimicrobial agents and chemotherapy 36 (5), 942-948, 1992 | 188 | 1992 |
| Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges R Nau, HW Prange, P Muth, G Mahr, S Menck, H Kolenda, F Sörgel Antimicrobial agents and chemotherapy 37 (7), 1518-1524, 1993 | 165 | 1993 |
| Paul Ehrlich (1854-1915) and his contributions to the foundation and birth of translational medicine P Valent, B Groner, U Schumacher, G Superti-Furga, M Busslinger, ... Journal of innate immunity 8 (2), 111-120, 2016 | 138 | 2016 |
| Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2. U Fuhr, G Strobl, F Manaut, EM Anders, F Sörgel, E Lopez-de-Brinas, ... Molecular pharmacology 43 (2), 191-199, 1993 | 138 | 1993 |
| Pharmacokinetic disposition of quinolones in human body fluids and tissues F Sörgel, U Jaehde, K Naber, U Stephan Clinical Pharmacokinetics 16, 5-24, 1989 | 137 | 1989 |
| Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers WA Krueger, J Bulitta, M Kinzig-Schippers, C Landersdorfer, U Holzgrabe, ... Antimicrobial agents and chemotherapy 49 (5), 1881-1889, 2005 | 129 | 2005 |
| Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers JB Bulitta, SB Duffull, M Kinzig-Schippers, U Holzgrabe, U Stephan, ... Antimicrobial agents and chemotherapy 51 (7), 2497-2507, 2007 | 128 | 2007 |
| Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy P Matzneller, S Krasniqi, M Kinzig, F Sörgel, S Hüttner, E Lackner, ... Antimicrobial agents and chemotherapy 57 (4), 1736-1742, 2013 | 127 | 2013 |
| Triamterene nephrolithiasis B Ettinger, NO Oldroyd, F Sörgel Jama 244 (21), 2443-2445, 1980 | 125 | 1980 |
